Many patients with myelodysplastic syndromes (MDS) have severe anaemia. However, regular blood transfusions, which are widely used to maintain quality of life and prevent anaemia-related morbidity and mortality, have a negative impact on survival as a result of iron overload. Retrospective surveys h
β¦ LIBER β¦
Iron overload in patients with myelodysplastic syndromes
β Scribed by Peter-D. Jensen
- Publisher
- Current Science Inc.
- Year
- 2007
- Tongue
- English
- Weight
- 222 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1558-8211
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The deleterious effects of iron overload
β
FranΓ§ois Dreyfus
π
Article
π
2008
π
Elsevier Science
π
English
β 127 KB
Iron overload and chelation therapy in p
β
Angel F. Remacha; Beatriz Arrizabalaga; Consuelo Del CaΓ±izo; Guillermo Sanz; Ana
π
Article
π
2009
π
Springer
π
English
β 147 KB
Overview of guidelines on iron chelation
β
Norbert Gattermann
π
Article
π
2008
π
Carden Jennings Publishing
π
English
β 175 KB
Red blood cell transfusions and iron ove
β
Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher
π
Article
π
2008
π
John Wiley and Sons
π
English
β 185 KB
π 2 views
## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie
No evidence for myocardial iron overload
β
Eli Konen; Husam Ghoti; Orly Goitein; Asher Winder; Tammi Kushnir; Yael Eshet; E
π
Article
π
2007
π
John Wiley and Sons
π
English
β 135 KB
π 2 views
Iron overload and iron chelation therapy
β
Emilio Paolo Alessandrino; Emanuele Angelucci; Mario Cazzola; Matteo Giovanni De
π
Article
π
2011
π
John Wiley and Sons
π
English
β 151 KB
π 2 views